Antagonists selective for NMDA receptors containing the NR2B subunit

Current Pharmaceutical Design

Volumn 5, Issue 5, 1999, Pages 381-404

  Chenard, B L ^a   Menniti, F S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 4 [3 [4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 HYDROXYPROPOXY]BENZAMIDE; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; BUPHENINE; CGP 61594; CP 283097; ELIPRODIL; GAVESTINEL; HALOPERIDOL; IFENPRODIL; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENYLETHANOLAMINE; RECEPTOR SUBUNIT; RO 045595; TRAXOPRODIL; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHANNEL GATING; DRUG SAFETY; DRUG STRUCTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; STRUCTURE ACTIVITY RELATION;

EXCITATORY AMINO ACID ANTAGONISTS; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0032914455     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Watkins, J. C.; Evans, R. H. Annual Review of Pharmacology & Toxicology 1981, 21, 165-204.
2. Johnson, J.W.; Ascher, P. Nature 1987, 325, 529-531.
3. Kleckner, N.W.; Dingledine, R. Science 1988, 241, 835-837.
4. Adams, S. L.; Foldes, R. L.; Kamboj, R. K. Biochimica et Biophysica Acta 1995, 1260, 105-108.
5. Das, S.; Sasaki, Y. F.; Rothe, T.; Premkumar, L. S.; Takasu, M.; Crandall, J. E.; Dikkes, P.; Conner, D. A.; Rayudu, P. V.; Cheung, W.; Chen, H. S.; Lipton, S. A.; Nakanishi, N. Nature 1998, 393, 377-381
6. Seeburg, P. H. Trends in Neurosci. 1993, 16, 359-365.
7. Durand, G. M.; Bennett, M. V.; Zukin, R. S. Proceedings of the National Academy of Sciences of the United States of America 1993, 90, 6731-6735.
8. Laube, B.; Hirai, H.; Sturgess, M.; Betz, H.; Kuhse, J. Neuron 1997, 18, 493-503.
9. Kuryatov, A.; Laube, B.; Betz, H.; Kuhse, J. Neuron 1994, 12, 1291-1300.
10. Clements, J. D.; Westbrook, G. L. Neuron 1991, 7, 605-613.
11. Monyer, H.; Burnashev, N.; Laurie, D. J.; Sakmann, B.; Seeburg, P. H. Neuron 1994, 12, 529-540.
12. Mayer, M. L.; Westbrook, G. L. Progress in Neurobiology 1987, 28, 197-276.
13. McBain, C. J.; Mayer, M. L. Physiological Reviews 1994, 74, 723-60: <49>.
14. Mattson, M. P. In Excitatory Amino Acids and Neuronal Plasticity; Ben-Ari, Y. Ed. Plenum Press: New York. 1990; pp 211-220.
15. Bear, M. F.; Malenka, R. C. Curr. Opin. Neurobiol. 1994, 4, 389-399.
16. Martinez, J. L. Jr.; Derrick, B. E. Annual Review of Psychology 1996, 47, 173-203.
17. Choi, D. W. Neuron 1988, I, 623-634.
18. Choi, D. W.; Koh, J. Y.; Peters, S. J. Neurosci. 1988, 8, 185-196.
19. McCulloch, J. J. Neural Transm. 1994, 71-79.
20. Bullock, R.; Kuroda, Y.; Teasdale, G. M.; McCulloch, J. Acta Neurochir. 1992, 55, 49-55.
21. Muir, K. W.; Lees, K. R. Stroke 1995, 26, 503-513.
22. Olney, J. W.; Labruyere, J.; Wang, G.; Wozniak, D. F.; Price, M. T.; Sesma, M. A. Science 1991, 254, 1515-1518.
23. Kemp, J. A.; Leeson, P. D. Trends Pharmacol. Sci. 1993, 14, 20-25.
24. Scatton, B.; Carter, C.; Claustre, Y.; L'Heureux, R.; Arbilla, S.; Langer, S.Z.; Gotti, B.; Duverger, D.; MacKenzie, E.T. Proc. Xth Int. Cong. Pharmacol., Sydney, Abstract No 012.064, 1987.
25. Carter, C.; Benavides, J.; Legendre, P.; Vincent, J.D.; Noel, F.; Thuret, F.; Lloyd, K.G.; Arbilla, S.; Zivkovic, B.; MacKenzie, E.T.; Scatton, B.; Langer, S.Z. J. Pharmacol. Exp. Ther., 1988, 247, 1222-1232.
26. Monyer, H.; Sprengel, R.; Schoepfer, R.; Herb, A.; Higuchi, M.; Lomeli, H.; Brunashev, N.; Sakmann, B.; Seeburg, P. Science, 1992, 256, 1217-1221.
27. Shoemaker, H.; Allen, J.; Langer, S.Z. Eur. J. Pharmacol., 1990, 176, 249-250.
28. Benavides, J.; Peny, B.; Allen, J.; Scatton, B. J. Pharmacol. Exp. Ther., 1992, 260, 896-901.
29. Hashimoto, K.; Mantione, C.R.; Spada, M.R.; Neumeyer, J.L.; London, E.D. Eur. J. Pharmocol. - Mol. Pharmacol. Section, 1994, 266, 67-77.
30. Nicolas, C.; Carter, C. J. Neurochem., 1994, 63, 2248-2258.
31. McCarthy, K.E.; Miller, S.A.; Chenard, B.L.; Butler, T.W.; Dumont, M.L.; Stemple, J.Z. J. Label. Comp. Radiopharm., 1997, XXXIX, 973-985.
32. Mutel, V.; Buchy, D.; Klingelschmidt, A.; Messer, J.; Bleuel, Z.; Kemp, J.A.; Richards, J.G. J. Neurochem., 1998, 70, 2147-2155.
33. Moriyoshi, K.; Masu, M.; Ishii, T.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Nature 1991 , 354, 31-37.
34. Grimwood, S.; Gilbert, E.; Ragan, C.I.; Hutson, P.H. J. Neurochem., 1996, 66, 2589-2595.
35. Honer, M.; Benke, D.; Laube, B.; Kuhse, J.; Hockendorn, R.; Allgeier, H.; Angst, C.; Monyer, H.; Seeburg, P.H.; Betz, H. J. Biol. Chem., 1998, 273, 11158-11163.
36. Chopra, B.; Chazot, P.L.; Mugnaini, M.; Stephenson, F.A. Br. J. Pharmacol., 1998, 123, Proc. Suppl. 131P.
37. Shalaby, I.A.; Chenard, B.L.; Prochniak, M.A.; Butler, T.W. J. Pharmacol. Exp. Ther., 1992, 260, 925-932.
38. Nakanishi, S. Science 1992, 258, 597-603.
39. Williams, K. Mol. Pharmacol. 1993, 44, 851-859.
40. Menniti, F.S.; Shah, A.K.; Williams, S.A.; Wilner, K.D.; White, W.F.; Chenard, B.L. CNS Drug Rev., 1998, 4, 307-322.
41. Chenard, B.L.; Shalaby, I.A.; Koe, B.K.; Ronau, R.T.; Butler, T.W.; Prochniak, M.A.; Schmidt, A.W.; Fox, C.B. J. Med. Chem., 1991, 34, 3085-3090.
42. Karbon, E.W.; Patch, R.J.; Pontecorvo, M.J.; Ferkany, J.W. Eur. J. Pharmacol., 1990, 176, 247-248.
43. Avenet, P.; Leonardon, J.; Besnard, F.; Graham, D.; Frost, J.; Depoortere, H.; Langer, S.Z.; Scatton, B. Eur. J. Pharmacol., 1996, 296, 209-213.
44. Biton, B.; Granger, P.; Carreau, A.; Depoortere, H.; Scatton, B.; Avenet, P. Eur. J. Pharmacol., 1994, 257, 297-301.
45. Biton, B.; Granger, P.; Depoortere, H.; Scatton, B.; Avenet, P. Eur. J. Pharmacol., 1995, 294, 91-100.
46. Giroux, C.; Rosen, P.; Scatton, B. In Pharmacology of Cerebral Ischemia: J. Krieglstein and H. Oberpichler-Schwenk, Eds., Wissenschaftliche Verlagsgeseltschaft; Stuttgart, 1994, pp. 643-648.
47. Bigge, C.F.; Cai, S.X.; Weber, E.; Woodward, R.; Keana, J.F.W.; Lan, N.C.; Guzikowski, A.P.; Zhou, Z.-L.; Yeun, P.-W. World Patent WO 97/23216.
48. Tamiz, A.P.; Wittemore, E.R.; Zhou, Z.-L.; Huang, J.-C.; Drewe, J.A.; Chen, J.-C.; Cai, S.-X.; Weber, E.; Woodward, R.M.; Keana, J.F.W. J. Med. Chem., 1998, 41, 3499-3506.
49. Bigge, C.F.; Cai, S.X.; Keana, J.F.W.; Lan, N.C.; Guzikowski, A.P.; Zhou, Z.-L.; Araldi, G.L.; Lamunyon, D.; Weber, E. World Patent WO 97/23458.
50. Chenard, B.L.; Bordner, J.; Butler, T.W.; Chambers, L.K.; Collins, M.A.; De Costa, D.L.; Ducat, M.F.; Dumont, M.L.; Fox, C.B.; Mena, E.E.; Menniti, F.S.; Nielsen, J.; Pagnozzi, M.J.; Richter, K.E.G.; Ronau, R.T.; Shalaby, I.A.; Stemple, J.Z.; White, W.F. J. Med. Chem. 1995, 38, 3138-3145.
51. Menniti, F.; Chenard, B.; Collins, M.; Ducat, M.; Shalaby, I.; White, F. Eur. J. Pharmacol., 1997, 331, 117-126.
52. Chenard, B.L. United States Patent 5, 338, 754.
53. Butler, T.W.; Blake, J.F.; Bordner, J.; Butler, P.; Chenard, B.L.; Collins, M.A.; DeCosta, D.; Ducat, M.J.; Eisenhard, M.E.; Menniti, F.S.; Pagnozzi, M.J.; Sands, S.B.; Segelstein, B.E.; Volberg, W.; White, W.F.; Zhao, D. J. Med. Chem. 1998, 41, 1172-1184.
54. Peroutka, S.J.; Snyder, S.H. Am. J. Psychiatry, 1980, 137, 1518-1522.
55. Monnet, F.P.; Debonnel, G.; Junien, J.-L.; De Montigny, C. Eur. J. Pharmacol., 1990, 179, 441-445.
56. Fletcher, E.J.; MacDonald, J.F. Eur. J. Pharmacol., 1993, 235, 291-295.
57. Ilyin, V.; Guastella, J.; Cai, S.X.; Weber, E.; Woodward, R.M. Soc. Neurosci. Abstr., 1994, 20, 1143.
58. Ilyin, V.I.; Wittemore, E.R.; Guastella, J.; Weber, E.; Woodward, R.M. Mol. Pharmacol., 1996, 50, 1541-1550.
59. Coughenour, L.L.; Cordon, J.J. J. Pharmacol. Exp. Ther., 1997, 280, 584-592.
60. Whittemore, E.R.; Ilyin, V.I.; Woodward, R.M. J. Pharmacol. Exp. Ther., 1997, 282, 326-338.
61. th National Meeting of the American Chemical Society, 1998, MEDI 115.
62. th National Meeting of the American Chemical Society, 1998, MEDI 116.
63. Bourson, A.; Fischer, G.; Heitz Neidhart, M.-P.; Mutel, V.; Trube, G. World Patent WO 97/32581.
64. Prucher, H.; Gottschlich, R.; Leibrock, J. World Patent WO 98/18793.
65. Alanine, A.; Butterlmann, B.; Heitz Neidhart, M.-P.; Pinard, E.; Wyler, R. European Patent EP 0 824 098 A1.
66. Chenard, B.L.; Butler, T.W. World Patent WO 96/06081.
67. Bigge, C.F.; Cai, S.X.; Weber, E.; Woodward, R.; Lan, N.C.; Keana, J.F.W.; Zhou, Z.-L.; Wright, J. World Patent WO 97/23214.
68. Butler, T.W. United States Patent 5,356,905.
69. Alanine, A.; Butterlmann, B.; Heitz Neidhart, M.-P.; Pinard, E.; Wyler, R. European Patent EP 0 846 683 A1.
70. Pruccher, H.; Leibrock, J.; Gottschlich, R.; Bartoszyk, G.; Seyfried, C. German Patent DE 19739332.
71. Whittemore, E.R.; Ilyin, V.I.; Konkoy, C.S.; Woodward, R.M. Eur. J. Pharmacol., 1997, 337, 197-208.
72. Tamiz, A.P.; Whittemore, E.R.; Schelkun, R.M.; Yuen, P.-W.; Woodward, R.M.; Cai, S.-X.; Weber, E.; Keana, J.F.W. Bioorg. Med. Chem. Lett., 1998, 8, 199-200.
73. Cai, S.X.; Keana, J.F.W.; Lan, N.C.; Araldi, G.L.; Tamiz, A.; Zhou, Z.-L.; Woodward, R.M.; Whittemore E.R.; Weber, E. World Patent WO 97/23202.
74. Bigge, C.F.; Cai, S.X.; Weber, E.; Woodward, R.; Lan, N.C.; Keana, J.F.W.; Guzikowski, A.P. World Patent WO 97/23215.
75. Kew, J.N.C.; Trube, G.; Kemp, J.A. Br. J. Pharmacol., 1998, 123, 463-472.
76. Gaudillier, B.; Rousseau, J. European Patent 0 202 164 A1.
77. Chenard, B.L. United States Patent 5, 185,343.
78. Ransom, R.W.; Stec, N.L. J. Neurochem., 1988, 51, 830-836.
79. Traynelis, S.F.; Hartley, M.; Heinemann, S.F. Science, 1995, 268, 873-876.
80. Gallagher, M.J.; Huang, H.; Grant, E.R.; Lynch, D.R. J. Biol. Chem., 1997, 272, 24971-24979.
81. Gallagher, M.J.; Huang, H.; Pritchett, D.B.; Lynch, D.R. J. Biol. Chem., 1996, 271, 9603-9611.
82. Reynolds, I.J. Eur. J. Pharmacol., 1990, 177, 215-216.
83. Sacaan, A.I.; Johnson, K.M. Mol. Pharmacol., 1990, 37, 572-577.
84. Williams, K.; Pullan, L.M.; Romano, C.; Powel, R.J.; Salama, A.I.; Molinoff, P.B. J. Pharmacol. Exp. Ther., 1992, 262, 539-545.
85. Bergeron, R.J.; Weimar, W.R.; Wu, Q.; Austin, J.K. Jr.; McManis, J.S. J. Med. Chem., 1995, 38, 425-428.
86. Williams, K.; Romano, C.; Dichter, M.A.; Molinoff, P.B. Life Sci., 1991, 48, 469-498.
87. Igarashi, K.; Williams, K. J. Pharmacol. Exp. Ther., 1995, 272, 1101-1109.
88. Igarashi, K.; Shirahata, A.; Pahk, A.J.; Kashiwagi, K.; Williams, K. J. Pharmacol. Exp. Ther., 1997, 283, 533-540.
89. Legendre, P.; Westbrook, G. L. Mol. Pharmacol. 1991, 40, 289-298.
90. Kew, J. N.; Trube, G.; Kemp, J. A. Journal of Physiology 1996, 497, 761-772.
91. Fischer, G.; Mutel, V.; Trube, G.; Malherbe, P.; Kew, J. N.; Mohacsi, E.; Heitz, M. P.; Kemp, J. A. Journal of Pharmacology & Experimental Therapeutics 1997, 283, 1285-1292.
92. Mott, D. D.; Doherty, J. J.; Zhang, S. N.; Washburn, M. S.; Fendley, M. J.; Lyuboslavsky, P.; Traynelis, S. F.; Dingledine, R. Nature Neuroscience 1998, 1, 659-667.
93. Brimecombe, J. C.; Boeckman, F. A.; Aizenman, E. Proceedings of the National Academy of Sciences of the United States of America 1997, 94, 11019-11024.
94. Vyklicky, L. ,Jr.; Vlachova, V.; Krusek, J. Journal of Physiology 1990, 430, 497-517.
95. Traynelis, S. F.; Cull-Candy, S. G. Nature 1990, 345, 347-350.
96. Tang, C. M.; Dichter, M.; Morad, M. Proceedings of the National Academy of Sciences of the United States of America 1990, 87, 6445-6449.
97. Williams, K.; Kashiwagi, K.; Fukuchi, J.; Igarashi, K. Mol. Pharmacol. 1995, 48, 1087-1098.
98. Kashiwagi, K.; Fukuchi, J.; Chao, J.; Igarashi, K.; Williams, K. Mol. Pharmacol. 1996, 49, 1131-1141.
99. Kashiwagi, K.; Pahk, A. J.; Masuko, T.; Igarashi, K.; Williams, K. Mol. Pharmacol. 1997, 52, 701-713.
100. Traynelis, S. F.; Burgess, M. F.; Zheng, F.; Lyuboslavsky, P.; Powers, J. L. J. Neurosci. 1998, 18, 6163-6175.
101. Traynelis, S. F.; Hartley, M.; Heinemann, S. F. Science 1995, 268, 873-876.
102. Williams, K. Cellular Signalling 1997, 9, 1-13.
103. Rock, D. M.; Macdonald, R. L. Annual Review of Pharmacology & Toxicology 1995, 35, 463-482.
104. Williams, K.; Zappia, A. M.; Pritchett, D. B.; Shen, Y. M.; Molinoff, P. B. Mol. Pharmacol. 1994, 45, 803-809.
105. Carter, C.; Rivy, J.-P.; Scatton, B. Eur. J. Pharmacol. 1989, 164, 611-612.
106. Carter, C. J.; Lloyd, K. G.; Zivkovic, B.; Scatton, B. J. Pharmacol. Exp. Ther. 1990, 253, 475-482.
107. Kew, J. N. C.; Kemp, J. A. Journal of Physiology-London 1998, 512, 17-28.
108. Brimecombe, J. C.; Gallagher, M. J.; Lynch, D. R.; Aizenman, E. Journal of Pharmacology & Experimental Therapeutics 1998, 286, 627-634.
109. Gallagher, M. J.; Huang, H.; Lynch, D. R. J. Neurochem. 1998, 70, 2120-2128.
110. Shim, S. S.; Gallagher, M. J.; Mutél, V.; Kemp, J. A.; Lynch, D. R. Soc. Neurosci. 1998, 28th Annual Meeting, pp. 43.5(Abstract).
111. Shim, S. S.; Gallagher, M. J.; Mutél, V.; Kemp, J. A.; Lynch, D. R. Soc. Neurosci. 1998, 28th Annual Meeting, pp. 43.5(Abstract).
112. Chazot, P. L.; Stephenson, F. A. J. Neurochem. 1997, 69, 2138-2144.
113. Chazot, P. L. Br. J. Pharmacol. (Suppl.), 1999, in press.
114. th National Meeting of the American Chemical Society, 1998, MEDI 114.